2.0
Feb 10, 2024
Former employee, more than 1 year
Basel
Recommend
CEO approval
Business Outlook
Pros
- large company with ability to get to know lots of departments - however although you can do this - getting things moving with the above is difficult!
Cons
- large, slow moving organisation - drug development seems to be left with poor quality leadership as many good people have left a while ago.